Monterey Bio Acquisition Stock (NASDAQ:MTRY)


OwnershipChart

Previous Close

$11.17

52W Range

$10.21 - $12.00

50D Avg

$11.21

200D Avg

$11.03

Market Cap

$48.30M

Avg Vol (3M)

$3.45K

Beta

-

Div Yield

-

MTRY Company Profile


Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Nov 22, 2021

Website

MTRY Performance


Peer Comparison


TickerCompany
TLGAElectriq Power Holdings, Inc.
JWSMJaws Mustang Acquisition Corporation